Systech International's new TIPS Serialized Product Tracking
solution software will aid in the fight against counterfeit and
diverted products within the pharmaceutical and healthcare
industries.
EU environment ministers met on Monday to further debate key issues
related to the chemical substances review, which has become one of
the fiercest political battlegrounds ever in the history of EU
policy definition.
Bionovo has announced data identifying a novel class of Oestrogen
receptor-subtype modulators, which provides solid evidence of a
potentially safer alternative treatment to hormone therapy that
treats hot flashes and night sweats.
Research Dynamics have struck a deal with VirtualScopics in which
they have signed a non-exclusive partnership agreement to co-market
their clinical research services and technologies.
Dharmacon and Alcon are to collaborate on the discovery of new
therapies for eye disease using RNAi technology. The specificity
and novel molecular mechanism of RNAi may allow for the development
of safer and more effective drugs...
A recently published report has revealed that less than 13 per cent
of US consumers believe that information provided by pharmaceutical
companies is more trustworthy than healthcare information provided
by other organisations.
According to a new report, the emergence of antibacterial
resistance is set to push antibiotic R&D back into the
spotlight in an attempt to slow down the increasing levels of drug
resistance that could well erode the medical advances...
Bruker AXS, a subsidiary of the Bruker BioSciences Corporation, has
announced an agreement to purchase Roentec, an x-ray microanalysis
instrumentation company that signals Bruker's intention to
reinforce its standing within this...
Actavis's $810 million (€677 million) cash acquisition of
Alpharma's US and international generic drugs division is part of
the firm's strategy to become one of the global leaders in the
sector.
The Food and Drug Administration has approved Flexbumin, the first
human albumin preparation to be packaged in a flexible container,
reducing the risk of breakage while being more compatible with
hospital inventory storage systems.
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported
third-quarter sales of €3,29 billion, a slight decrease from the
previous quarter but up 5.4 per cent from the comparable period in
2004, thanks to growth in all its units,...
Roche has formed a research collaboration with Epitomics, giving
Roche a license to Epitomics' monoclonal antibody technology
(RabMab technology) for the discovery and development of monoclonal
antibodies to treat cancer and...
New Life Scientific and CureLab have identified an anti fungal
compound that represents a significant breakthrough as part of a
joint collaboration, which has demonstrated immunostimulating and
antibacterial properties.
According to a new report, worldwide revenues for cell and cytokine
therapies in regenerative medicine are set to reach $20.7 billion
(€17.3 billion) in 2010 in a sector that provides a viable
alternative to using drugs or other therapies.
Procyon has announced preclinical results for its lead HIV protease
inhibitor that has demonstrated cross-resistance profile and
multi-drug resistant strains of HIV-1 compared to other HIV
protease inhibitors, which are fast becoming...
Olympus Microscopes announces the launch of two new microscopy
products that aims to further improve live cell imaging conditions
that characterises drug development.
Chiron has warned it will yet again fall short of targets for its
US flu vaccine deliveries this year due to continuing production
problems with its British manufacturing plant.
Sterling Biotech, India's largest gelatin producer, has struck a
deal with Gujarat Biotech (TGBL) to purchase its manufacturing unit
for Rs 55 cr ($12.3 million) in an all cash deal. Sterling's
acquisition brings it one...
The first non-injectable insulin treatment in Europe may soon
become available after a panel of experts recommended it for
regulatory approval on Thursday.
European Authorities recommended the first needle-free system for
acute postoperative pain for approval this week, which allows
patient-controlled delivery of fentanyl in post-operative pain
control.
Bangledeshi's Beximco Pharmaceuticals has announced that the
company has raised $21 million after it successfully completed an
institutional placing of global depositary receipts (GDRs).
Clinical trials for what may be the first effective culture-based
vaccine against the highly-pathogenic avian influenza viruses will
begin in Norway in Spring 2006.
Dendritic Nanotechnologies (DNT) has signed a collaboration
agreement with Nanotechnology Characterisation Laboratory (NCL),
which is focused on the discovery and development of dendrimer
technologies.
The GEA Group has acquired the manufacturer of freeze dryers for
pharmaceutical products, STERIS, a unit of US-based STERIS
Corporation in a deal that aims to strengthen the group's Process
Engineering Division in the Process...
BASF has announced it is to reduce production at one of its main
sites in a move that reflects the declining demand for
pseudoephedrine and caffeine caused by a change in prescription
regulations and pricing pressures.
A new antibiotic that not only acts as a traditional antibiotic but
also acts on bacterial infections that have developed resistance to
existing types of antibiotic could herald the emergence of a new
tool to fight infections.
Roche has launched what it claims is the first commercially
available instrument for high-throughput DNA sequencing, enabling
sequencing of genomes and long DNA sequences up to 100 x faster
than current Sanger-based methods.
Scientists have demonstrated that a mouse virus that causes mammary
cancer can infect human cells. This latest study attempts to shed
light on a debate stretching back to the early 70's, which show
that a viral-like agent may...
Drugs, which stick to a key protein in the bloodstream, could help
to create drugs that are delivered more effectively to organs in
the body. The latest research, which points to a more effective
delivery of therapy, could improve...
Researchers have discovered a species of seaweed that could yield
new compounds with pharmaceutical potential, some of which showed
the potential to kill cancer cells, bacteria and even the HIV
virus.
Materials company, Micromuscle, has developed an electro-active
polymer technology that allows the controlled release of liquid
medications that reflect an emerging class of advanced materials
with new revolutionary properties.
Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.
Dynatek dalta Scientific Instruments are to introduce its
drug-eluting stent tester to audiences throughout the US and
Europe, signifying the first time a coating durability tester for
medical devices has been commercially available.
Cargill-Cerestar is to unveil a new excipient developed on the back
of a directly compressible excipient platform that allows tablets
to be produced using lower compression forces.
Freeman Technology introduces its new aeration control unit for its
FT4 Powder Rheometer, which allows airflow control through a powder
under test, enabling the automated measurement of the powder's flow
properties.
A new technique that adds to the effectiveness of gene therapy has
made a breakthrough after it was revealed that the method had cured
phenylketonuria (PKU) in mice.
Enzo Biochem, announced that pre-clinical experiments with its
small molecule candidate suggests it would have applications in
strengthening bones weakened by age or as a consequence of certain
medications.
Researchers are developing breakthrough diabetes drugs that use
modified forms of a naturally occurring molecule produced by the
body. The approach characterises the major investments by the
biopharmaceutical industry to develop and...
A new generation of portable, handheld radiation detectors that
could have a range of potential applications from disease diagnosis
is the target for researchers from the UK, who have been awarded
almost £1.2 million as part of a...
Roche Molecular Systems and Primagen today entered talks to form a
collaboration that develops dry filter spot technology for HIV-1
viral load testing in the developing world.
The Marchesini Group introduces its new range of blister line
machinery that is set to reduce the time it takes to carry out
validation and get into production, which is aimed at manufacturers
in the pharmaceutical, cosmetics and...
Life sciences is to be given priority under a European Commission
(EU) framework, which focuses on creating a knowledge-based economy
to ensure increased funding for this industry.
The battle to gain control of UK filtration specialist Domnick Hunter took a dramatic turn after favourites to gain control, Eaton, admitted defeat, leaving rival bidder Parker Hannifin poised to complete the multimillion pound acquisition.
With recent waste and packaging directives proposed by the EU,
Catchpoint have responded by trialling a backless label, which
renders the backing on labels obsolete, reducing approximately
100,000 tons of waste produced per year attributed...
German laboratory and process equipment company Sartorius has
acquired a 100 per cent stake in Omnimark Instrument of the US,
boosting its activities in the moisture analysis sector.
Invitrogen has announced two additional acquisitions in the area of
nanotechnologcal tools for target and drug discovery, just as it
completes the earlier-announced purchase of Biosource
International.
Innovation in targeted areas like nutrition should add sales worth
€1 billion in five years time, said vitamin and specialty chemicals
maker DSM today.
Sweden's Biotage, a specialist in microwave synthesis and
chromatography systems for drug development and production, has
taken some of its European distribution into its own hands through
the purchase of Separtis Holding.
